Long-term Risk of Serious Infections and Mortality Among Patients Surviving Drug Use-Associated Infective Endocarditis

Clin Infect Dis. 2024 Jul 19;79(1):56-59. doi: 10.1093/cid/ciae214.

Abstract

Among a statewide cohort of 1874 patients surviving hospitalization for drug use-associated endocarditis during 2017-2020, the 3-year risk of death or future hospitalization was 38% (16% for death before later infection, 14% for recurrent endocarditis, 14% for soft tissue, 9% for bacteremia, 5% for bone/joint, and 4% for spinal infections).

Keywords: bacterial infections; endocarditis; injection drug use; mortality.

MeSH terms

  • Adult
  • Aged
  • Bacteremia / mortality
  • Cohort Studies
  • Endocarditis* / mortality
  • Endocarditis, Bacterial / mortality
  • Female
  • Hospitalization / statistics & numerical data
  • Humans
  • Male
  • Middle Aged
  • Risk Factors
  • Substance-Related Disorders / complications
  • Substance-Related Disorders / mortality